Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGB for Hot Flashes in Hispanic Women with Breast Cancer
NCT03122301Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Jun 2017
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in hot flashes, sponsored by Northwestern University. Primary endpoint: Subject Reported Daily Hot Flashes at 2 months. Started Jun 2017; status: terminated.
02
Drugs
bupivacaine
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT03122301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03122301.